Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications

Abstract

The COVID-19 pandemic constitutes an arduous global health challenge, and the increasing number of fatalities calls for the speedy pursuit of a remedy. This review emphasizes the changing aspects of the COVID-19 disease, featuring the cytokine storm’s pathological processes. Furthermore, we briefly reviewed potential therapeutic agents that may modulate and alleviate cytokine storms. The literature exploration was made using PubMed, Embase, MEDLINE, Google scholar, and China National Knowledge Infrastructure databases to retrieve the most recent literature on the etiology, diagnostic markers, and the possible prophylactic and therapeutic options for the management of cytokine storm in patients hospitalized with COVID-19 disease. The causative agent, severe acute respiratory coronavirus-2 (SARS-CoV-2), continually threatens the efficiency of the immune system of the infected individuals. As the first responder, the innate immune system provides primary protection against COVID-19, affecting the disease’s progression, clinical outcome, and prognosis. Evidence suggests that the fatalities associated with COVID-19 are primarily due to hyper-inflammation and an aberrant immune function. Accordingly, the magnitude of the release of pro-inflammatory cytokines such as interleukin (IL)-1, (IL-6), and tumor necrosis alpha (TNF-α) significantly differentiate between mild and severe cases of COVID-19. The early prediction of a cytokine storm is made possible by several serum chemistry and hematological markers. The prompt use of these markers for diagnosis and the aggressive prevention and management of a cytokine release syndrome is critical in determining the level of morbidity and fatality associated with COVID-19. The prophylaxis and the rapid treatment of cytokine storm by clinicians will significantly enhance the fight against the dreaded COVID-19 disease.

A Rare Case of Henoch-Schönlein Purpura Following a COVID-19 Vaccine—Case Report

“…In the same logic, a lot of infections including COVID-19 are associated with the release of cytokines, the primary immune system regulators. Some of these cytokines can dysregulate the immune system and contribute to an inflammatory state called the cytokine storm [ 17 ] that increases between day 5 and day 13 [ 18 ]. It is known in the literature that the cytokine storm can be the gateway to certain auto-immune diseases.…”

Efficacy and Safety of Corticosteroid Use in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis

“…The pathophysiology of COVID-19 includes host-mediated excessive inflammation and cytokine storm that causes severe endothelial and alveolar damage [ 69 ]. COVID-19-related death is mainly due to excessive inflammation and uncontrolled immune response [ 70 ]. Corticosteroids are well tolerated and widely used worldwide.…”

COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab

“…Indeed, serum derived from COVID19 patients was associated with acute cardio-depressant and chronic pro-arrhythmogenic effects in both, rat and iPS-CM. This impairment of Ca 2+ release might be associated with the serum protein and cytokine profile of our set of ICU COVID19 patients: It has been shown that levels of IL-1, TNFα, IL6 and other cytokines are significantly increased in patients resembling our clinical collective with COVID19 [ 23 – 25 ]. However, of note, 92% of the patients included in this study received antibiotic treatment at the time of sample acquisition.…”